Mon, August 15, 2022

Nathan Weinstein Maintained (VNRX) at Strong Buy with Decreased Target to $6 on, Aug 15th, 2022

Nathan Weinstein of Aegis Capital, Maintained "VolitionRx Limited" (VNRX) at Strong Buy with Decreased Target from $9 to $6 on, Aug 15th, 2022.

Nathan, nor any peers, have made any analyst calls on VNRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30